(UroToday.com) Following three presentations regarding novel treatment approaches for first-line treatment of patients with metastatic hormone-sensitive prostate cancer in the Prostate, Testicular, and Penile Oral Abstract session at the 2021 American Society of Clinical Oncology Annual Meeting, Dr. Lisa Horvath provided a discussant overview of these data and the rapidly moving disease space of metastatic hormone-sensitive prostate cancer.